Home > Miscellaneous > BBAC 2011: Day Eight

BBAC 2011: Day Eight

Posted on Thursday, at • bought • 309 views

I tend to be a cautious MMU buyer. I don't necessarily go scouting Etsy or Artfire or where-have-you for the latest indie companies to try out. I tend to try a few here and there, based on what I see on a few beauty blogs whose opinions I generally trust. (For example: I haven't tried one particular vendor because while they seem to have good buzz around the beauty blogosphere - including recommends from a handful of bloggers whose opinions I trust pretty highly - they don't really have many colors that I personally am interested in.)

BBAC 2011: Day Eight

Still…I do try new vendors. Some I only buy from the once, others I keep returning to their shop. Sometimes a vendor has offers so compelling, that I go just a wee tiny bit nutso. Such is the case with My Pretty Zombie. I had kind of been aware of this company for a while, but hadn't really seen any swatch photos that made me start drooling, so I didn't wander over to the shop. And then…Toxid Lotus posted about the new Drugs Like Me blushes, and posted some swatch photos of MDMA, a gorgeous duochrome blush that looks excellent with my coloring. So wait: coral-pink? with gold duochrome? Oh, yeah, sign me up!!! (LSD and THC are also duochromes, albeit not as dramaticly so as MDMA.)

A good portion of the products are duochrome. Most of the eyeshadows are pretty saturated colors, though there are a few neutrals and softer shades. There are a few sets available as well, including Geekily Ever After, a collaboration with the owner of Geek Chic cosmetics. And hey, Toxid-lotus is hosting a sweepstakes for a set of all five MPZ blushes! The winner will be chosen on December 21, 2011. Head over, see the swatches, and enter to win!

Check out all the days' links on our advent calendar. Don't forget to go visit my co-conspirators Phyrra and Sirvinya!

Like this entry? Check these out:


or look at other entries tagged with Beauty Blog Advent Calendar

Comments

Commenting is not available in this channel entry.